Filing Details

Accession Number:
0000711377-19-000007
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-22 16:50:23
Reporting Period:
2019-04-17
Accepted Time:
2019-04-22 16:50:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-04-17 3,000 $56.04 360,373 No 4 S Indirect See Footnote
Common Stock Disposition 2019-04-17 2,600 $56.03 357,773 No 4 S Indirect See Footnote
Common Stock Disposition 2019-04-18 17,000 $56.08 340,773 No 4 S Indirect See Footnote
Common Stock Disposition 2019-04-18 18,400 $56.11 322,373 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. Following the transactions on 4/17 and 4/18, 57,521 shares remain in a charitable remainder trust in which Mr. Herbert and his wife are beneficiaries and trustees. A total of 21,000 shares were sold out of this trust in these two days of transactions.Mr. Herbert's spouse sold a total of 20,000 shares out of her trust; 104,880 remain in the trust. The remainder of the shares held indirectly are held in limited liability companies in which Mr. Herbert and his spouse hold minority financial positions.